Recognizing the role of information and communication technology (ICT) in health, the Department of Science and Technology (DOST) and the Department of Health (DOH) will hold the first Philippine eHealth Summit on 4 February 2014 at the Sofitel Philippine Plaza, Manila.

With the theme, “eHealth Innovations for Universal Health Care (UHC),” the summit will not just be a venue for exchange of information and expertise on current eHealth initiatives in the country but also for presenting the Philippine eHealth Strategic Framework and Plan to gather inputs from stakeholders.

One of the important eHealth programs is the setting up of the Philippine Health Information Exchange (PHIE) to ensure the availability of health information, crucial in making informed decisions for both health practitioners and policy-makers. The PHIE will be an enabling system of interoperably health-related information, databases and registries linking all health services, users and providers.

The Summit will also feature the eHealth Marketplace and Poster Exhibit competition. The eHealth Marketplace is a platform for the government, private and industry sectors, ICT developers, international development organizations, academe, to meet, discuss, and form partnerships on eHealth innovations to support the Kalusugang Pangkalahatan (Universal Health Care). The poster exhibit contest, meanwhile, is a competition for undergraduate students and professionals on eHealth researches, projects and applications.

The Conseil Europeen pour la Recherche Nucleaire (CERN) Summer Student Program offers undergraduate students of physics, computing and engineering a unique opportunity to join in the day-to-day work of research teams participating in experiments at CERN in Geneva, Switzerland.

Potential students must be university-level undergraduates at least in their third year of bachelors/Masters degree, must possess a good knowledge in English (knowledge of French is advantage), have not worked at CERN, and will remain as a student during its stay at CERN.

Attendance requires a presence of 8 weeks on site. Possible dates of stay are the following:

  • 16 July to 8 August
  • 23 June to 15 August
  • 30 June to 22 August
  • 7 July to 29 August – in exceptional circumstances only

The deadline for submission of application is fixed on 31 January 2014 (00:00 CET !).

For more information, visit http://jobs.web.cern.ch/job/10947

Science and health communities in the whole world are rejoicing after a novel treatment successfully cured blood cancers.

Using genetically engineered cells, the researchers from the University of Pennsylvania (UPenn) developed a new therapy system called personalized cellular therapy that cured 26 adults with chronic lymphocytic leukemia (CLL) and 19 children suffering from acute lymphoblastic leukemia (ALL).

The process starts by extracting T-cells, a type of white blood cells from the patient’s own immune system. The T-cells are then genetically reprogrammed and multiplied in the laboratory and reintroduce to the patient’s body.

After its infusion, the genetically engineered T-cells will proliferate inside patient’s body and attack tumor cells through its anti-body like protein called chimeric antigen receptors (CAR) designed to bind and kill cancerous cells. This process will manifest severe flu-like symptoms, high fevers, nausea, and in some cases breathing difficulties to patients.

Results after four weeks of treatment showed that 85 percent of the paediatric patients with ALL and 40 percent of the adults with CLL have complete remissions -- a first time in history of leukaemia treatment gaining high positive response regardless of patient’s age and extent of the disease.

The study also emphasized that unlike the traditional cancer treatments such as chemotherapy, surgical therapy and radiation therapy which have tremendous side effects to patients, personalized cellular therapy leaves no collateral damages to patient’s body. Genetically engineered T-cells specifically target cancer cells and provide continues vaccine-like activity that prevents B-cells (presumably tumour cells) from growing back.

University of the Philippines Manila – National Institutes of Health (UPM-NIH) invites abstract submission for oral or poster presentation in the 16th UPM-NIH Anniversary celebration and the 12th University Science and Technology week.

Submission of abstracts must be through the Newborn Screening Reference Center via email to This email address is being protected from spambots. You need JavaScript enabled to view it. attention to Ms. Marian. Deadline of submission is on 22 January 2014.

 
 

The Department of Science and Technology (DOST) through the Food and Nutrition Research Institute (FNRI) will run a six-month feeding project to provide nutrient-rich food by January 2014 to typhoon Yolanda victims.

Around four million people have been left homeless and 10 million are affected by typhoon, based on the latest report of the government. The demand for food is huge and more feeding projects are needed.  However, typhoon victims need the right diet with calories, proteins, and vitamins than relief goods for temporary sustenance, according to the FNRI Director Mario Capanzana (the project leader).

To meet these nutritional needs of typhoon victims, Dr. Capanzana and his team will give ready-to-eat or complementary foods, which are appropriate for emergency feeding and for monitoring effects of this type of food on Filipinos’ nutrition.

The products are made from rice and mongo like BIGMO Instant Baby food for six months to two years old, Nutri-MAM, snack food for one to five years old, Nutri-Bites (rice power bar and compressed food), and BIGMO curls for all age groups. (Hope R. Bongolan/PCHRD)